Pharmaceutical company
Appears in 2 stories · Last updated Nov 21, 2026
Named on the full building permit
Two two-story apartment buildings that had stood on North Sedgwick Street since 1883 have been torn down. The five-story, 27-unit building replacing them received its full construction permit on November 21, 2026.
Updated 1 hour ago
Sponsor of BE BOLD and maker of bimekizumab (BIMZELX)
Bimekizumab kept a higher joint-response rate than risankizumab at every visit through Week 24 of the BE BOLD trial. At the final analysis, 54.9% of patients on bimekizumab reached ACR50, a 50% improvement on a standard arthritis scale, against 43.8% on risankizumab.
Updated Nov 9
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?